MedTrace Logo

Italian Registry of Allergen ImmunoTherapy

NCT06499480 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-03-06

No results posted yet for this study

Summary

RIAIT (Italian Registry of Allergy Immunotherapy) is a multicenter observational study that aims to prospectively collect the most extensive data available on Italian patients using AIT for respiratory allergies (rhinoconjunctivitis and/or asthma) in a real-life context, through a network of allergy centers with specific interest and expertise in the management of allergic respiratory patients.

Conditions

  • Allergic Respiratory Disease

Sponsors & Collaborators

  • Società Italiana di Allergologia e Immunologia Pediatrica (SIAIP)

    collaborator UNKNOWN

  • Società Italiana di Allergologia, Asma e Immunologia Clinica

    lead OTHER

Principal Investigators

  • Enrico Marco Heffler, MD, PhD · Humanitas Research Hospital IRCCS, Rozzano-Milan

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06499480 on ClinicalTrials.gov